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Abstract
Background: The World Health Organization (WHO), like many other organisations around the world, has
recognised the need to use more rigorous processes to ensure that health care recommendations are informed
by the best available research evidence. This is the first of a series of 16 reviews that have been prepared as
background for advice from the WHO Advisory Committee on Health Research to WHO on how to achieve this.
Objectives: We reviewed the literature on guidelines for the development of guidelines.
Methods: We searched PubMed and three databases of methodological studies for existing systematic reviews
and relevant methodological research. We did not conduct systematic reviews ourselves. Our conclusions are
based on the available evidence, consideration of what WHO and other organisations are doing and logical
arguments.
Key questions and answers: We found no experimental research that compared different formats of
guidelines for guidelines or studies that compared different components of guidelines for guidelines. However,
there are many examples, surveys and other observational studies that compared the impact of different guideline
development documents on guideline quality.
What have other organizations done to develop guidelines for guidelines from which WHO can
learn?: • Establish a credible, independent committee that evaluates existing methods for developing guidelines
or that updates existing ones.
• Obtain feedback and approval from various stakeholders during the development process of guidelines for
guidelines.
• Develop a detailed source document (manual) that guideline developers can use as reference material.
What should be the key components of WHO guidelines for guidelines?: • Guidelines for guidelines
should include information and instructions about the following components: 1) Priority setting; 2) Group
composition and consultations; 3) Declaration and avoidance of conflicts of interest; 4) Group processes; 5)
Identification of important outcomes; 6) Explicit definition of the questions and eligibility criteria ; 7) Type of study
designs for different questions; 8) Identification of evidence; 9) Synthesis and presentation of evidence; 10)
Specification and integration of values; 11) Making judgments about desirable and undesirable effects; 12) Taking
account of equity; 13) Grading evidence and recommendations; 14) Taking account of costs; 15) Adaptation,
applicability, transferability of guidelines; 16) Structure of reports; 17) Methods of peer review; 18) Planned
methods of dissemination & implementation; 19) Evaluation of the guidelines.
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What have other organizations done to implement guidelines for guidelines from which WHO can
learn?: • Obtain buy-in from regions and country level representatives for guidelines for guidelines before
dissemination of a revised version.
• Disseminate the guidelines for guidelines widely and make them available (e.g. on the Internet).
• Develop examples of guidelines that guideline developers can use as models when applying the guidelines for
guidelines.
• Ensure training sessions for those responsible for developing guidelines.
• Continue to monitor the methodological literature on guideline development.
Background
The World Health Organization (WHO), like many other
organisations around the world, has recognised the need
to use more rigorous processes to ensure that health care
recommendations are informed by the best available
research evidence. This is the first of a series of 16 reviews
that have been prepared as background for advice from
the WHO Advisory Committee on Health Research to
WHO on how to achieve this.
The term guideline can be defined as "a rule or principle
that provides guidance to appropriate behaviour" [1]. The
Institutes of Medicine define clinical practice guidelines as
"systematically developed statements to assist practitioner
and patient decision about appropriate health care for
specific clinical circumstances". The term "guidelines" in
this document should be seen in the broad sense referring
to any guideline or recommendation related to healthcare
that is relevant to the mission of the WHO, including pub-
lic health and health policy recommendations. A plethora
of guidelines for clinical practice guidelines exist from var-
ious organizations, including national and governmental
agencies and medical specialty societies. There are fewer
guidelines for developing public health and health policy
recommendations. We will use the term "guidelines for
guidelines" as "guidelines for the development of guide-
lines and recommendations".
Guidelines for guidelines are important because of reports
indicating that the lack of standardized guideline develop-
ment leads to widely varying recommendations [2]. In
this paper we addressed the following questions:
￿ What have other organizations done to develop guide-
lines for guidelines from which WHO can learn?
￿ What should be the key components of WHO guidelines
for guidelines?
￿ What have other organizations done to implement
guidelines for guidelines from which WHO can learn?
What WHO is doing now
An inter-cluster initiative (Guideline Development
Group) led by the Evidence and Information for Policy
(EIP) cluster produced the "Guidelines for WHO Guide-
lines" (GWG) as the recommended approach to develop-
ment of WHO guidelines [3]. The process for developing
the WHO document included drafting of the GWG by one
group member before revision and approval by the com-
mittee. Following approval by the group, this document
was reviewed and approved during a cabinet meeting
before distribution as a technical cluster note to all WHO
members.
The GWG (version March 10, 2003) included the follow-
ing general proposals for process (see GWG "WHO docu-
ments that guide the development, dissemination and
implementation of recommendations by WHO" section
5):
"b) choice of [guideline] topics; c) synthesis of the evi-
dence; d) formulation of recommendations; e) dissemi-
nation of guidelines". The GWG makes special reference
to the National Health and Medical Research Council
(NHMRC) of Australia guidelines for guidelines. To
accomplish proper guideline development the GWG rec-
ommends partnerships within and outside WHO accord-
ing to a defined set of rules. Specific functions and
composition of guideline groups are also described. The
GWG also includes advice for the operationalisation of
the process (section 6 GWG): a) Selection of partners; b)
Organization of guideline groups; c) Process of develop-
ing guidelines; d) Guiding values. The committee also
produced a self assessment checklist to ensure a consistent
level of quality in the guidelines.
Although comprehensive in the coverage of topics, due to
brevity most sections of the GWG could not provide the
same level of detailed instructions for guideline groups to
follow that other organizations provide. Moreover, it is
not entirely clear to what extent WHO guideline develop-
ers adhere to the GWG, but it appears that few depart-
ments have used the GWG [4]. In part this may be a resultHealth Research Policy and Systems 2006, 4:13 http://www.health-policy-systems.com/content/4/1/13
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of a lack of a more detailed handbook that WHO guide-
lines development committees could follow, although
there are a number of other possible explanations.
What other organisations are doing?
The use and quality of guidelines for guidelines varies
across organizations that develop guidelines. There is not
an accepted international standard for guideline develop-
ment. However, there are several specific and detailed
examples of methods adopted by other organizations.
Some of these are exemplary because they give detailed
guidance and resulted from a thorough process. For exam-
ple, the National Institute for Health and Clinical Excel-
lence (NICE) and the Scottish Intercollegiate Guideline
Network (SIGN), both large government agencies that
develop guidelines, have produced comprehensive hand-
books that provide guidance for its guideline developers
[5,6]. A number of professional organizations have also
developed detailed guidance documents that advise their
guideline developers about methods including the devel-
opment of templates [7-10].
We describe the single steps of what other organizations
do in regards to guideline development and on what
grounds they do it in other articles in this series (see [11]
for a list of articles). The steps go from setting priorities for
guideline topics to implementation of the guidelines. In
addition, literature has emerged from independent
groups, such as the Conference on Guideline Standardiza-
tion [12], that address the critical appraisal of guidelines
and suggest the need for guidance for each of these steps
of guideline development [13]. For example, one tool (the
AGREE instrument) has demonstrated its sensitivity to
differentiate higher quality guidelines that followed tech-
nical documentation from those of lower quality [14].
Methods
The methods used to prepare this review are described in
the introduction to this series [11]. Briefly, the key ques-
tions addressed in this paper were vetted amongst the
authors and the ACHR Subcommittee on the Use of
Research Evidence (SURE). As a result of prior work in the
area of guideline methodology we had knowledge of
existing guidelines for guidelines by organisations such as
NICE, SIGN, the US Preventive Services Task Force (USP-
STF), the New Zealand Guideline Group and the Austral-
ian NHRMC as well as professional societies such as the
American College of Chest Physicians (ACCP) and the
American Thoracic Society (ATS). We attempted to search
PubMed, but were unable to devise a search strategy that
was both sensitive and reasonably specific.
Given time constraints we avoided duplication with work
of others and focused on sources that had systematically
compiled relevant literature. We searched databases main-
tained by the Agency for Healthcare Research and Quality
(AHRQ [15]), the Guidelines International Network (GIN
[16]), information obtained from prominent organiza-
tions and our own files. The AHRQ database (guideline
development methodology and guideline structure) is a
comprehensive database that included 1205 references to
both journal but also non-journal sources. The GIN data-
base included 104 references. While there was overlap we
reviewed these citations in detail and evaluated each of
these references for relevance. The answers to the ques-
tions are our conclusions based on the available evidence,
consideration of what WHO and other organisations are
doing and logical arguments.
Findings
We found no experimental research that compared differ-
ent formats of guidelines for guidelines or studies that
compared different components of guidelines for guide-
lines. However, there are many examples, surveys and
other observational studies of the impact of guideline
development documents on guideline quality.
What have other organizations done to develop guidelines 
for guidelines that WHO can learn from?
Many large organizations that claim to develop evidence
based guidelines have produced accessible, transparent
and detailed guidelines for guidelines. To make a guide-
line for guideline credible and acceptable, individuals
with expertise in methodology, process and implementa-
tion of guidelines were involved in developing a guideline
for guideline document. For example, NICE involved not
only various internal groups (the national collaborating
centres that develop guidelines, NICE patient involve-
ment units, etc.), but also external advisors, including
individual academics and governmental institutions (e.g.
SIGN) [5]. SIGN and the RAND corporation published a
detailed description of the processes involved in produc-
ing guidelines for guidelines involving various stakehold-
ers [6,17].
Other guideline developers carefully select the panels that
produce guidelines for guidelines ensuring that method-
ologists and clinicians as well as representatives of the
organization are involved. Most specialty societies have
included experts and authorities in the relevant fields.
While this bears the risk of involving individuals with less
methodological and, therefore, relevant training for
guideline development, it ensures that individuals who
are knowledgeable about the relevant clinical aspects,
including ongoing research, are represented and may sup-
ports buy-in by users. Aspects focusing on group processes
and selection including patient representation are
described in other articles in this series [18,19]. Most
organizations obtain approval of the final document by a
board or other governing body. While no experimentalHealth Research Policy and Systems 2006, 4:13 http://www.health-policy-systems.com/content/4/1/13
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research indicates that providing a source document (e.g.
a handbook) for guideline developers improves the qual-
ity of guidelines, observational studies suggest that organ-
izations publishing their guidelines for guidelines in the
form of reference material produce more methodologi-
cally sound guidelines [20].
What should be the key components of WHO guidelines 
for guidelines?
We have identified 19 components that are already or
should be included in the GWG and that should be
described in detail in a handbook or manual for WHO
guideline developers. Other reviews in this series will
describe these components in greater detail. We list in
parenthesis the review that describes the component in
more detail and the section of the GWG that has men-
tioned the component. The sections in the GWG cited
below often consist of a single sentence. The components
are:
1) Priority setting ([21] and GWG 5b "Choice of topics for
development of WHO guidelines")
2) Group composition (and consultations) ([22] and
GWG 6A "Organization of guideline groups")
3) Declaration and avoidance of conflicts of interest ([23]
and GWG 6B Note 1, annex A)
4) Group processes ([24] and GWG 6C3 "Process of devel-
oping guidelines")
5) Identification of important outcomes including cost
([25], not addressed in GWG)
6) Explicit definition of the question and eligibility crite-
ria ([26,27], not addressed in GWG)
7) Type of study designs for different types of questions
([27], not addressed in GWG)
8) Identification of evidence ([27], GWG 6C2 "Undertake
a systematic review")
9) Synthesis and presentation of evidence ([28] and GWG
5C "Synthesizing the evidence")
10) Specification and integration of values ([29] and
GWG 6D "Guiding values")
11) Making judgments about desirable and undesirable
effects ([29] and [30] and GWG 5d "Making recommen-
dations")
12) Taking account of equity ([31], not addressed in
GWG)
13) Grading evidence and recommendations ([30] and
GWG Annex B)
14) Taking account of costs ([32] and GWG 5d "Making
recommendations")
15) Applicability, transferability and adaptation of guide-
lines ([33] and GWG 5a "A 3 stage process")
16) Structure of reports ([34] and GWG 6C)
17) Methods of peer review ([20] and [32]not addressed
in GWG)
18) Planned methods of dissemination & implementa-
tion ([35] and GWG 5e "Dissemination of guidelines")
19) Evaluation of the impact of the guideline ([36] and
GWG 6C6)
What have other organizations done to implement 
guidelines for guidelines from which WHO can learn?
Other prominent guideline developers, such as NICE and
SIGN, have ensured that those stakeholders who will
become involved in guideline development also take part
in the development of the guidelines for guideline. Simi-
larly, obtaining buy-in from regions and country level rep-
resentatives for GWG before agreeing on and
disseminating a revised version is likely to be important.
Once WHO reaches agreement on a revised version of the
GWG, it should be widely disseminated and made easily
available (e.g. on the Internet).
Examples and worksheets should be provided to facilitate
implementation of the GWG. In addition, WHO should
ensure training sessions for those responsible for develop-
ing guidelines. In their survey of 18 prominent interna-
tional clinical guideline developers, Burgers and
colleagues found that almost all guideline programs offer
(in some organizations mandatory) training sessions to
guideline developers [37]. SIGN, for example, offers a spe-
cific software program to guideline panel members and
helps them with identifying specific learning needs [6].
SIGN also electronically records the amount of training of
individuals who contribute to the guidelines.
The GWG should not be a static document. NICE, for
example, has outlined the process for updating its guide-
lines for guidelines. This specifies that the formal process
for updating its manual will begin three years after publi-
cation of the original manual. Interim updates may be
completed to accommodate small changes outside of theHealth Research Policy and Systems 2006, 4:13 http://www.health-policy-systems.com/content/4/1/13
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regular renewal process. NICE specifies four criteria that
must all be fulfilled to qualify for a minor update: a fun-
damental stage in the guideline for guideline process is
neither added nor removed, a fundamental methods tech-
nique or step is neither added nor removed, one or more
stakeholders will not obviously be disadvantaged, and the
efficiency, clarity or fairness of the process or methodol-
ogy will be improved. To develop revisions of the GWG,
WHO should monitor the methodological literature on
guideline development and review updates of other
organizations' guidelines for guidelines.
Discussion
The studies we identified and practical experience suggest
that guidelines for guidelines facilitate the development
of guidelines. Our review is limited in that it is not a sys-
tematic review and is based on our own judgments. How-
ever, our review has identified practical advice and
components that a handbook or manual that accompany
the GWG should include.
Although WHO's leadership has endorsed the GWG, a
detailed handbook does not exist. Moreover, implemen-
tation of the GWG in WHO guideline programs appears to
be very limited [4]. Potential reasons for this shortcoming
are discussed elsewhere [4]. Key explanations include a
lack of resources, technical (methodological) capacity,
knowledge about the GWG, and a tradition of using non-
systematic, expert opinion-based approaches [4]; as well
as a lack of training and a lack of a more detailed manual.
Other organizations have invested substantial resources
into guideline development, including resources to
develop and implement guidelines for guidelines.
Because WHO has limited resources and because well
described processes used by other organizations already
exist, WHO can build on existing high quality guidelines
for guidelines. As we discuss in another article in this
series, WHO should also consider adapting guidelines
developed by other organizations, if high quality guide-
lines already exist [33]. In addition, WHO should con-
sider establishing collaborations with other guideline
developers to avoid unnecessary duplication of efforts and
use of resources.
Further work
A systematic review of guidelines for guidelines is unlikely
to yield empirical information beyond what we have
found in this review, but could provide useful informa-
tion about what other organisations are doing with
respect to key steps in the guideline development process.
We do not consider such a review to be a priority for
WHO. Similar information has been obtained through
surveys [20, 38, 39]. More information about specific
questions regarding, for example, processes that are used
for updating, implementing and evaluating guidelines for
guidelines, is more likely to come from further surveys
than from a systematic review.
WHO should develop a handbook or manual that pro-
vides detailed information and examples for its guideline
developers. This handbook should build on existing
work, but will require time and resources. Nonetheless,
this is likely necessary to improve the quality of WHO
guideline development.
Efforts are needed that ensure guideline developers begin
speaking the same "guideline" language and improve the
standardisation of the guideline development processes
used by WHO. This standardisation would help facilitate
the production of guidelines that can easily be adapted to
different contexts, and thus reduce global resources spent
on guideline development, particularly for low and mid-
dle-income countries [33]. WHO should participate in
international efforts aimed at improving guidelines for
guidelines, and should aim to take a leading role in these
efforts in the future.
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